HEALWELL AI has made an acquisition that will present the company with immediate upsell opportunities., says Raymond James ...

TD Cowen analyst Vince Valentini says he is feeling more bullish about Quebecor, and has raised his price target on it.

Following the company’s fourth quarter results, Ventum Capital Markets analysts Andrew Semple has maintained his “Buy” rating ...

Delayed financials from WELL Health mean an opportunity for investors, says Ventum Capital Markets analyst Rob Goff.

Ahead of the company’s fourth quarter results, CIBC analyst Todd Coupland has maintained his “Buy” rating and $7.00 price ...

Following the company’s fourth quarter results, Beacon analyst Russell Stanley has cut his price target on Cematrix.

Following the company’s fourth quarter results, ATB Capital analyst Martin Toner has cut his price target on Bitfarms.

Its fourth quarter results are in the books and Ventum Capital Markets analyst Andrew Semple thinks there is still good money ...

Following the company’s fourth quarter results, Citi analyst Vikram Bagri has cut his price target on Canadian Solar.

Following the company’s fourth quarter results, Paradigm Capital analyst Daniel Rosenberg has maintained his “Buy” rating on ...

The stock is already a Canadian success story, but Raymond James analyst Michael W. freeman thinks there is still money to be ...

Following the company’s fourth quarter results, Roth analyst Suji Desilva has maintained his “Buy” rating on Intuitive ...